Dermatology Times, February 2026 (Vol. 47. No. 02)

Learn more about the in-depth topics covered in the February 2026 print issue of Dermatology Times.

Even without deep penetration, peptide moisturizers can improve the skin’s appearance through hydration and smoothing effects.

Around 800 rare skin diseases affect 6.8 million people worldwide, including epidermolysis bullosa, generalized pustular psoriasis, ichthyosis, and erythropoietic protoporphyria.

NIH Sister Study ties hair straightener use to higher pancreatic and thyroid cancer risk, but experts say methods limit certainty.

Des Fernandes, MBBCh, FRCS (Edin), pioneered microneedling as a safe skin regeneration therapy, demonstrating collagen gains and improved scars when paired with vitamins A and C.

This issue highlights clinical insights relevant to inflammatory conditions in diverse populations, emphasizing practical strategies for everyday practice.

The consensus summarizes contemporary real-world data showing that nearly 1 in 5 adolescents and adults with atopic dermatitis receive systemic corticosteroids.

A new molecular test offers clinicians a way to personalize treatment for moderate to severe atopic dermatitis and reduce therapeutic cycling, helping to achieve faster control and a better experience for patients.

Takeda’s recent announcement of positive top-line phase 3 results for zasocitinib (TAK-279) places this investigational agent squarely within that evolving conversation.